Epidemiological characteristics and spatiotemporal clustering of hepatitis A in Yuxi, Yunnan, 2005−2020
-
摘要:
目的 分析2005—2020年云南省玉溪市甲型病毒性肝炎(甲肝)流行特征与时空聚集性,为甲肝防控提供理论依据。 方法 从国家传染病报告信息管理系统下载2005年1月1日至2020年12月31日的相关资料。 描述甲肝病例的三间分布特征,季节性分析采用改良的集中度M值分析法,不同年龄亚组的甲肝报告发病率比较采用Poisson回归分析。 根据甲肝疫苗纳入免疫规划时间,划分为2005—2008年和2009—2020年两个时期,应用GeoDa 1.14软件完成全局及局部空间自相关分析,SaTScan 9.7软件进行时空扫描分析。 结果 2005—2020年玉溪市累计报告甲肝病例1451例,年均报告发病率为3.92/10万,由2005年的8.36/10万下降至2020年的1.60/10万(趋势χ2=456.272,P<0.001)。 除2005年和2012年甲肝发病有一定季节性外,其余年份无明显季节性。 报告病例年龄中位数呈上升趋势(P=0.004),0~9岁、10~19岁和20~59岁亚组报告发病率均呈下降趋势(均趋势性P<0.001);2011—2020年≥20岁组发病风险均高于0~9岁组(均RR>1,P<0.05)。 年均报告发病率的趋势由西向东逐渐升高,由北向南逐渐升高再缓慢下降。 局部空间自相关分析显示:2005—2008年,通海县九龙街道、四街镇和高大乡为高-高聚集区域;2009—2020年,通海县四街镇为高–高聚集区域。时空扫描分析发现:2007年、2010年存在时空聚集区,其中2007年的Ⅱ类聚集区转变为2010年的I类聚集区。 结论 2005—2020年玉溪市甲肝发病呈下降趋势,发病年龄高峰后移,时空聚集区主要集中在玉溪市中部和东南,需重点关注并制定区域化的精准防控策略,有效遏制甲肝疫情。 Abstract:Objective To analyze the epidemiological characteristics and spatiotemporal clustering of hepatitis A in Yuxi prefecture, Yunnan province, during 2005−2020, and suggest countermeasures for hepatitis A prevention and control. Methods The incidence data of hepatitis A in Yuxi from January 1, 2005 to December 31, 2020 were downloaded from National Notifiable Disease Report System. The population, time and space distributions of hepatitis A cases was described, the seasonality of hepatitis A incidence was analyzed using improved muster method, and the Poisson regression models was used to compare the reported incidence of hepatitis A in different age groups. The data during 2005−2008 (before the inclusion of hepatitis A vaccine into immunization program) and during 2009−2020 (after the inclusion of hepatitis A vaccine into immunization program) were used in the analysis. Software GeoDa 1.14 was used in global and local spatial autocorrelation analyses, and software SaTScan 9.7 was used in spatiotemporal scanning analysis. Results A total of 1451 hepatitis A cases were reported in Yuxi during this period, the average annual incidence rate was 3.92/100 000, the incidence rate decreased from 8.36/100 000 in 2005 to 1.60/100 000 in 2020 (trend χ2=456.272, P<0.001), no obvious seasonality of the incidence of hepatitis A was observed except 2005 and 2012. The median of age of the cases showed an increasing trend (P=0.004), and the incidences showed decreasing trends in age group 0–9, 10–19 and 20−59 years (all of the P<0.001). From 2011 to 2020, the incidence risk was higher in age group ≥20 years than in age group 0−9 years (all RR>1, P<0.05). The average incidence increased gradually from the west to the east, but increased then decreased gradually from the north to the south in Yuxi. The local spatial autocorrelation analysis showed that the high-high clustering areas at tow level were Jiulong, Sijie and Gaoda in Tonghai county from 2005 to 2008 and Sijie in Tonghai county from 2009 to 2020. The spatiotemporal scanning analysis revealed that there were spatiotemporal clustering areas in 2007 and 2010, and the spatiotemporal clustering areas changed from type Ⅱ in 2007 to type I in 2010. Conclusion The incidence of hepatitis A decreased in Yuxi from 2005 to 2020 and the incidence peaked gradually in older age group. The spatiotemporal clustering areas were observed in the central and southeast areas of Yuxi, specific prevention and control strategy is needed to reduce the incidence of hepatitis A. -
表 1 2005-2020年玉溪市不同年龄亚组甲型病毒性肝炎报告发病率
Table 1. The reported incidence of hepatitis A of different age subgroups in Yuxi prefecture, 2005−2020
年份 0~9岁 10~19岁 20~59岁 ≥60岁 发病率
(/10万, 95%CI)RR值 发病率
(/10万, 95%CI)RR值(95%CI) 发病率
(/10万, 95%CI)RR值 (95%CI) 发病率
(/10万, 95%CI)RR值(95%CI) 2005—2006 25.45
(21.04~29.86)1.000 11.40
(8.87~13.92)0.490
(0.372~0.646)5.97
(5.05~6.90)0.234
(0.186~0.296)3.98
(2.31~5.64)0.159
(0.102~0.249)2007—2008 23.42
(19.25~27.60)1.000 12.45
(9.78~15.14)0.488
(0.367~0.648)3.89
(3.15~4.62)0.166
(0.128~0.215)2.64
(1.17~3.75)0.108
(0.063~0.187)2009—2010 6.67
(4.46~8.89)1.000 5.47
(3.73~7.21)0.818
(0.519~1.291)4.26
(3.49~5.02)0.632
(0.434~0.919)3.12
(1.68~4.56)0.474
(0.270~0.831)2011—2012 2.26
(0.98~3.54)1.000 2.70
(1.49~3.91)1.177
(0.579~2.395)3.00
(2.37~3.64)1.284
(0.709~2.324)3.42
(1.92~4.92)1.490
(0.738~3.011)2013—2014 0.56
(0.00~1.19)1.000 0.99
(0.26~1.72)1.617
(0.455~5.751)2.49
(1.91~3.06)3.834
(1.311~11.21)2.71
(1.38~4.04)4.284
(1.352~13.577)2015—2016 0.74
(0.01~1.46)1.000 0.42
(0.00~0.89)0.587
(0.145~2.372)2.84
(2.23~3.46)3.441
(1.332~8.886)4.20
(2.55~5.84)5.150
(1.890~14.029)2017—2018 0.18
(0.00~0.54)1.000 0.55
(0.01~1.10)2.264
(0.357~14.368)2.17
(1.64~2.71)7.945
(1.574~40.109)4.48
(3.08~6.60)17.873
(3.465~92.182)2019—2020 0.19
(0.00~0.56)1.000 0.00
(0.00~0.00)0.252
(0.010~6.174)2.34
(1.77~2.90)8.320
(1.649~41.968)2.92
(1.53~4.30)10.603
(2.001~56.181)趋势χ2=576.032,P<0.001 趋势χ2=297.157,P<0.001 趋势χ2=94.626,P<0.001 趋势χ2=7.936,P=0.338 注:RR. 相对危险度, CI. 置信区间 表 2 2005-2020年玉溪市甲型病毒性肝炎发病时空扫描分析
Table 2. The spatio-temporal scanning analysis of the incidence of hepatitis A in Yuxi prefecture, 2005−2020
时间阶段(年) 聚集区域 乡 镇 聚集时间(年) RR值 LLR值 P值 2005-2008 Ⅰ类 羊街乡、那诺乡、澧江街道、咪哩乡、红河街道、洼垤乡、龙潭乡 2007 2.592 9.216 0.003 Ⅱ类 河西镇、兴蒙乡、九龙街道、四街镇、纳古镇、研和街道、高仓街道、九溪镇、小街街道 2007 1.759 7.364 0.017 2009-2020 Ⅰ类 河西镇、兴蒙乡、九龙街道、四街镇、纳古镇、研和街道、高仓街道、九溪镇、小街街道 2010 6.232 43.520 <0.001 Ⅱ类 富良棚乡、塔甸镇、双江街道、大龙潭乡、岔河乡、甸中镇、洛河乡、桂山街道、新化乡、古城街道、平甸乡、老厂乡、扬武镇、绿汁镇、浦贝彝族乡 2010 2.316 6.907 0.017 注:RR. 相对危险度,LLR. 对数似然比 -
[1] Feinstone SM, Kapikian AZ, Purcell RH. Hepatitis A: Detection by immune electron microscopy of a viruslike antigen associated with acute illness[J]. Science, 1973, 182(4116): 1026–1028. DOI: 10.1126/science.182.4116.1026. [2] Wang FZ, Sun XJ, Wang F, et al. Changing epidemiology of hepatitis A in China: evidence from three national serological surveys and the national notifiable disease reporting system[J]. Hepatology, 2021, 73(4): 1251–1260. DOI: 10.1002/hep.31429. [3] Zhu B, Liu JL, Fu Y, et al. Spatio-temporal epidemiology of viral hepatitis in China (2003-2015): implications for prevention and control policies[J]. Int J Environ Res Public Health, 2018, 15(4): 661. DOI: 10.3390/ijerph15040661. [4] 马俊才, 李顺祥, 李六九, 等. 玉溪市某小学甲型肝炎爆发调查[J]. 中国热带医学,2006,6(6):1005. DOI:10.3969/j.issn.1009−9727.2006.06.035.Ma JC, Li SX, Li LJ, et al. Survey of an outbreak of hepatitis A in a primary school in Yuxi city[J]. China Trop Med, 2006, 6(6): 1005. DOI: 10.3969/j.issn.1009−9727.2006.06.035. [5] 车鑫仁, 孙昼, 许二萍, 等. 杭州市2004-2013年甲型和戊型肝炎流行病学特征分析[J]. 中华流行病学杂志,2015,36(4):409–410. DOI:10.3760/cma.j.issn.0254−6450.2015.04.025.Che XR, Sun Z, Xu EP, et al. Epidemiological characteristics of hepatitis A and E in Hangzhou, 2004−2013[J]. Chin J Epidemiol, 2015, 36(4): 409–410. DOI: 10.3760/cma.j.issn.0254−6450.2015.04.025. [6] 孙校金, 王富珍, 郑徽, 等. 中国2004-2015年不同预防接种阶段甲型肝炎和戊型肝炎流行病学特征比较[J]. 中华流行病学杂志,2018,39(10):1351–1355. DOI:10.3760/cma.j.issn.0254−6450.2018.10.012.Sun XJ, Wang FZ, Zheng H, et al. Epidemiological characteristics of hepatitis A and hepatitis E in different periods of vaccination in China, 2004−2015[J]. Chin J Epidemiol, 2018, 39(10): 1351–1355. DOI: 10.3760/cma.j.issn.0254−6450.2018.10.012. [7] 孙校金, 王富珍, 郑徽, 等. 2004-2015年中国甲型病毒性肝炎流行病学特征分析[J]. 中华预防医学杂志,2017,51(12):1091–1096. DOI:10.3760/cma.j.issn.0253−9624.2017.12.008.Sun XJ, Wang FZ, Zheng H, et al. Epidemiological analysis of viral hepatitis A in China, 2004−2015[J]. Chin J Prev Med, 2017, 51(12): 1091–1096. DOI: 10.3760/cma.j.issn.0253−9624.2017.12.008. [8] Carrillo-Santisteve P, Tavoschi L, Severi E, et al. Seroprevalence and susceptibility to hepatitis A in the European Union and European Economic Area: a systematic review[J]. Lancet Infect Dis, 2017, 17(10): e306–e319. DOI: 10.1016/S1473−3099(17)30392−4. [9] Cao GY, Jing WZ, Liu J, et al. The global trends and regional differences in incidence and mortality of hepatitis A from 1990 to 2019 and implications for its prevention[J]. Hepatol Int, 2021, 15(5): 1068–1082. DOI: 10.1007/s12072−021−10232−4. [10] Sun XJ, Wang FZ, Zheng H, et al. The impact of expanded program on immunization with live attenuated and inactivated Hepatitis A vaccines in China, 2004–2016[J]. Vaccine, 2018, 36(10): 1279–1284. DOI: 10.1016/j.vaccine.2018.01.043. [11] Sun XJ, Zhang GM, Zhou RJ, et al. Changes in the epidemiology of hepatitis A in three socio-economic regions of China, 1990–2017[J]. Infect Dis Poverty, 2019, 8(1): 80. DOI: 10.1186/s40249−019−0591−z. [12] 张之伦, 朱向军, 丁亚兴, 等. 天津市2000-2011年甲型肝炎免疫控制效果评价[J]. 中华流行病学杂志,2014,35(10):1127–1130. DOI:10.3760/cma.j.issn.0254−6450.2014.10.011.Zhang ZL, Zhu XJ, Ding XY, et al. Evaluation on the hepatitis A vaccine in preventing hepatitis A infection in Tianjin, from 2000 to 2011[J]. Chin J Epidemiol, 2014, 35(10): 1127–1130. DOI: 10.3760/cma.j.issn.0254−6450.2014.10.011. [13] Souto FJD, De Brito WI, Fontes CJF. Impact of the single-dose universal mass vaccination strategy against hepatitis A in Brazil[J]. Vaccine, 2019, 37(6): 771–775. DOI: 10.1016/j.vaccine.2018.12.054. [14] Koibuchi T, Koga M, Kikuchi T, et al. Prevalence of hepatitis A immunity and decision-tree analysis among men who have sex with men and are living with human immunodeficiency virus in Tokyo[J]. Clin Infect Dis, 2020, 71(3): 473–479. DOI: 10.1093/cid/ciz843. [15] Foster MA, Hofmeister MG, Albertson JP, et al. Hepatitis A virus infections among men who have sex with men - eight U. S. States, 2017–2018[J]. MMWR Morb Mortal Wkly Rep, 2021, 70(24): 875–878. DOI: 10.15585/mmwr.mm7024a2. [16] Sachdeva H, Benusic M, Ota S, et al. Community outbreak of hepatitis A disproportionately affecting men who have sex with men in Toronto, Canada[J]. Can Commun Dis Rep, 2019, 45(10): 262–268. DOI: 10.14745/ccdr.v45i10a03. [17] 董文斌, 赵金仙, 李世福, 等. 400例MSM行为特征及HIV、HAV、HCV、HEV、梅毒感染状况的横断面调查[J]. 现代预防医学,2019,46(10):1875–1878,1903.Dong WB, Zhao JX, Li SF, et al. Cross-sectional survey of behavioral characteristics and infection status of HIV, HAV, HCV, HEV, syphilis among 400 men who had sex with men[J]. Mod Prev Med, 2019, 46(10): 1875–1878,1903. [18] Wang H, Gao P, Chen WX, et al. Changing epidemiological characteristics of hepatitis A and warning of Anti-HAV immunity in Beijing, China: a comparison of prevalence from 1990 to 2017[J]. Hum Vaccin Immunother, 2019, 15(2): 420–425. DOI: 10.1080/21645515.2018.1529128. [19] Yan BY, Lv JJ, Liu JY, et al. Changes in seroprevalence of hepatitis A after the implementation of universal childhood vaccination in Shandong province, China: A comparison between 2006 and 2014[J]. Int J Infect Dis, 2019, 82: 129–134. DOI: 10.1016/j.ijid.2019.03.005. [20] Chen CM, Chen SCC, Yang HY, et al. Hospitalization and mortality due to hepatitis A in Taiwan: a 15-year nationwide cohort study[J]. J Viral Hepat, 2016, 23(11): 940–945. DOI: 10.1111/jvh.12564. [21] Mayorga O, Bühler S, Jaeger VK, et al. Single-dose hepatitis A immunization: 7.5-year observational pilot study in Nicaraguan children to assess protective effectiveness and humoral immune memory response[J]. J Infect Dis, 2016, 214(10): 1498–1506. DOI: 10.1093/infdis/jiw411. [22] 王树坤, 王志刚, 张晓和, 等. 云南省元江县2010-2011年一起甲型副伤寒暴发调查与处置[J]. 中华流行病学杂志,2017,38(2):200–204. DOI:10.3760/cma.j.issn.0254−6450.2017.02.013.Wang SK, Wang ZG, Zhang XH, et al. An outbreak of paratyphoid fever in a county of Yunnan province, 2010−2011[J]. Chin J Epidemiol, 2017, 38(2): 200–204. DOI: 10.3760/cma.j.issn.0254−6450.2017.02.013. [23] 王树坤, 吴强, 杨汝松, 等. 云南省一起O139群霍乱弧菌引起食源性霍乱暴发的调查[J]. 中华流行病学杂志,2010,31(10):1202–1203. DOI:10.3760/cma.j.issn.0254−6450.2010.10.032.Wang SK, Wu Q, Yang RS, et al. Investigation of an outbreak of food-borne cholera caused by Vibrio cholerae O139 in Yunnan province[J]. Chin J Epidemiol, 2010, 31(10): 1202–1203. DOI: 10.3760/cma.j.issn.0254−6450.2010.10.032. [24] Gullón P, Varela C, Martínez EV, et al. Association between meteorological factors and hepatitis A in Spain 2010–2014[J]. Environ Int, 2017, 102: 230–235. DOI: 10.1016/j.envint.2017.03.008. -